Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
B Norrving - Thrombosis Research, 2020 - Elsevier
Abstract Introduction Direct oral anticoagulants (DOACs) have been proven non-inferior or
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation.
M Jansson, S Själander, V Sjögren, H Renlund… - Thrombosis …, 2019 - europepmc.org
Materials and methods Patients with newly initiated DOAC treatment were identified from the
Swedish anticoagulation quality registry, ranging from January 1, 2013 to December 31 …
Swedish anticoagulation quality registry, ranging from January 1, 2013 to December 31 …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren, H Renlund… - Thrombosis …, 2020 - lup.lub.lu.se
Introduction: Direct oral anticoagulants (DOACs) have been proven non-inferior or superior
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren… - Thrombosis …, 2020 - thrombosisresearch.com
Abstract Introduction Direct oral anticoagulants (DOACs) have been proven non-inferior or
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren… - Thrombosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Direct oral anticoagulants (DOACs) have been proven non-inferior or superior
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren… - Thrombosis …, 2020 - portal.research.lu.se
Abstract Introduction: Direct oral anticoagulants (DOACs) have been proven non-inferior or
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren, H Renlund… - Thrombosis …, 2020 - diva-portal.org
Materials and methods: Patients with newly initiated DOAC treatment were identified from
the Swedish anticoagulation quality registry, ranging from January 1, 2013 to December 31 …
the Swedish anticoagulation quality registry, ranging from January 1, 2013 to December 31 …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren, H Renlund… - Thrombosis …, 2020 - diva-portal.org
Introduction: Direct oral anticoagulants (DOACs) have been proven non-inferior or superior
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
to warfarin in preventing stroke and systemic embolism, with a lower risk of major …